MUC1 and neoplasm: To date, four tumor vaccines targeting MUC1 have entered clinical trials: MUC1 peptide vaccine, antiMUC1 monoclonal antibody vaccine, MUC1-specific immune cell vaccine, and MUC1-expressing recombinant viral vector vaccine.